Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$27.8B
sum of reported positions
Reported positions
934
Changes vs prior quarter
1068
158 new · 177 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 342 measured positions in 8 quarters, the typical new or larger position finished −3.7 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $23.8B | $27.8B |
| Positions | 953 | 934 |
| Biggest line | — | NVIDIA 6% |
| 656K |
| $757M |
| 2.7% |
| 1.74M | $648M | 2.3% |
| 1.73M | $521M | 1.9% |
| 2.22M | $396M | 1.4% |
| 2.56M | $394M | 1.4% |
| 1.62M | $386M | 1.4% |
| 482K | $368M | 1.3% |
| 2.18M | $316M | 1.1% |
| 2.27M | $296M | 1.1% |
| 3.4M | $296M | 1.1% |
| 145K | $287M | 1.0% |
| 3.49M | $269M | 1.0% |
| 117K | $265M | 1.0% |
| 2.77M | $251M | 0.9% |
| 914K | $238M | 0.9% |
| 284K | $236M | 0.8% |
| 921K | $232M | 0.8% |
| 533K | $231M | 0.8% |
| 606K | $229M | 0.8% |
| 3.42M | $219M | 0.8% |
| 4.14M | $213M | 0.8% |
| 448K | $200M | 0.7% |
Cytomx Therapeutics (CTMX)
68K shares in Q1 2026
Ryerson Holding (RYZ)
68K shares in Q1 2026
Acuity Brands (AYI)
66K shares in Q1 2026
Leonardo Drs (DRS)
65K shares in Q1 2026
Sotera Health (SHC)
64K shares in Q1 2026
Ball Corporation (BALL)
64K shares in Q1 2026
TAYLOR MORRISON HOME CORP
63K shares in Q1 2026
LegalZoom.com, Inc. (LZ)
63K shares in Q1 2026
Hayward Holdings, Inc. (HAYW)
62K shares in Q1 2026
APELLIS PHARMACEUTICALS INC
62K shares in Q1 2026
Ennis (EBF)
61K shares in Q1 2026
Organon & Co. (OGN)
59K shares in Q1 2026
Lennox International (LII)
59K shares in Q1 2026
COTERRA ENERGY INC
56K shares in Q1 2026
CARDLYTICS INC
53K shares in Q1 2026
Veritone (VERI)
53K shares in Q1 2026
Cigna (CI)
50K shares in Q1 2026
Alaska Air Group (ALK)
49K shares in Q1 2026
Ameren (AEE)
48K shares in Q1 2026
Expensify (EXFY)
48K shares in Q1 2026
Nautilus Biotechnology (NAUT)
46K shares in Q1 2026
Amerant Bancorp (AMTB)
45K shares in Q1 2026
Atea Pharmaceuticals (AVIR)
43K shares in Q1 2026
Omniab (OABI)
43K shares in Q1 2026
Claritev (CTEV)
40K shares in Q1 2026